Zhejiang Jolly Pharmaceutical Co., Ltd. logo

Zhejiang Jolly Pharmaceutical Co., Ltd. (300181)

Market Open
11 Aug, 06:57
XSHE XSHE
¥
14. 63
+0.27
+1.8802%
¥
12.06B Market Cap
- P/E Ratio
2.4% Div Yield
7.21M Volume
- Eps
¥ 14.36
Previous Close
Add Transaction
Day Range
14.41 14.66
Year Range
12.3 21.07
Want to track 300181 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

300181 trading today higher at ¥14.63, an increase of 1.8802% from yesterday's close, completing a monthly increase of 4.5% or ¥0.63. Over the past 12 months, 300181 stock lost -9.6914%.
300181 pays dividends to its shareholders, with the most recent payment made on May 28, 2026. The next estimated payment will be in In 9 months on May 28, 2027 for a total of ¥0.35.
The last earnings report, released on May 09, 2025, exceeded the consensus estimates by 0.2616%. On average, the company has surpassed earnings expectations by 0.2201%, based on the last three reports.
Zhejiang Jolly Pharmaceutical Co., Ltd. has completed 3 stock splits, with the recent split occurring on May 20, 2015.
The company's stock is traded on one exchange.

300181 Chart

People also search for

Aier Eye Hospital Group Co. Ltd.
¥ 9.05
-0.2205%
Haisco Pharmaceutical Group Co., Ltd.
¥ 70.17
-0.1565%
Shannon Semiconductor Tech Inc.
¥ 155.64
-0.6384%
Sichuan Kelun Pharmaceutical Co., Ltd.
¥ 47.33
+1.9823%
Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
¥ 27.47
-0.5431%

Zhejiang Jolly Pharmaceutical Co., Ltd. (300181) FAQ

What is the stock price today?

The current price is ¥14.63.

On which exchange is it traded?

Zhejiang Jolly Pharmaceutical Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 300181.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.4%.

What is its market cap?

As of today, the market cap is 12.06B.

Has Zhejiang Jolly Pharmaceutical Co., Ltd. ever had a stock split?

Zhejiang Jolly Pharmaceutical Co., Ltd. had 3 splits and the recent split was on May 20, 2015.

Zhejiang Jolly Pharmaceutical Co., Ltd. Profile

Pharmaceuticals Industry
Healthcare Sector
Mr. Tao Wang CEO
XSHE Exchange
CNE100001096 ISIN
CN Country
2,125 Employees
28 May 2026 Last Dividend
4 Mar 2014 Last Split
22 Feb 2011 IPO Date

Overview

Zhejiang Jolly Pharmaceutical Co.,LTD, established in 1995 and headquartered in Huzhou, the People's Republic of China, is a pioneering company dedicated to the research, production, and international marketing of Chinese medicinal products. Initially founded as Zhejiang Jolly Pharmaceutical Health Products Co., LTD, it underwent a name change in 1998 to better reflect its broadened scope and commitment to advancing traditional Chinese medicine. The company is deeply involved in the medical services sector, notably through its investments and participations in the medical operations of Deqing No.3 People's Hospital. With a rich history and a robust product portfolio, Zhejiang Jolly Pharmaceutical Co.,LTD stands at the forefront of integrating traditional Chinese medicinal solutions with modern healthcare services.

Products and Services

  • Wuling Capsule

    Designed to tackle a range of symptoms including insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, giddy tinnitus, and other symptoms associated with the disharmony of heart and kidney or neurasthenia. This capsule is a representation of the company's commitment to addressing complex health issues with nuanced herbal formulations.

  • Lingze Tablet

    A solution for those suffering from urinary difficulties and discomforts such as frequent urination, dysuria, weak steam of urine, endless urine, as well as soreness and weakness of waist and knees. These symptoms are often caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis, and Lingze Tablet offers a targeted treatment option.

  • Bailing Tablet

    Utilized as an adjuvant therapy, the Bailing Tablet can assist in the treatment of cough, asthma, back pain, and chronic bronchitis that are rooted in the deficiency of lungs and kidney. Through its unique composition, this tablet aids in alleviating chronic respiratory and back issues.

  • Linglianhua Particles

    Addressing the multifaceted symptoms of perimenopausal syndrome or disharmony of heart and kidney, such as sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, along with weak pulse. This product exemplifies how traditional Chinese medicine interprets and addresses complex syndromes.

  • Pharmaceutical Injections

    The company extends its healthcare solutions with a range of pharmaceutical injections including azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside. These injections cater to various acute and chronic conditions, demonstrating Zhejiang Jolly Pharmaceutical's versatility in product offerings.

  • Materials

    In addition to finished medicinal products, Zhejiang Jolly Pharmaceutical also specializes in the production and supply of critical raw materials such as cordyceps cephalosporium, fermented cordyceps, and Wuling powders. These materials are foundational to several of the company's proprietary formulations as well as to the broader market of Chinese medicinal products.

Contact Information

Address: No. 388, Zhiyuan North Road, Huzhou, China, 313200
Phone: 86 57 2828 1088